Intraperitoneal chemotherapy

Phase I study of intravenous oxaliplatin and intraperitoneal docetaxel in recurrent ovarian cancer
Sarah E Taylor, Jennifer S Petschauer, Heidi Donovan, Allison Schorzman, Juan Razo, William C Zamboni, Robert P Edwards, Kristin K Zorn

International Journal of Gynecologic Cancer Jan 2019, 29 (1) 147-152; DOI: 10.1136/ijgc-2018-000055
Investigating the Impact of Body Mass Index on Intraperitoneal Chemotherapy Outcomes in Ovarian and Fallopian Tube Cancer
Michelle Davis, Emeline Aviki, J. Alejandro Rauh-Hain, Michael Worley, Ross Berkowitz, John Schorge, Michael Muto, Rachel Clark Sisodia, Neil Horowitz, Marcela del Carmen

International Journal of Gynecologic Cancer Jul 2016, 26 (6) 1033-1040; DOI: 10.1097/IGC.0000000000000729
Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer
Michelle M. Boisen, Jamie L. Lesnock, Scott D. Richard, Sushil Beriwal, Joseph L. Kelley, Kristin K. Zorn, Robert P. Edwards

International Journal of Gynecologic Cancer May 2016, 26 (4) 626-631; DOI: 10.1097/IGC.0000000000000667
Prognostic Significance of the Number of Postoperative Intraperitoneal Chemotherapy Cycles for Patients With Advanced Epithelial Ovarian Cancer
Rudy S. Suidan, Qin Zhou, Alexia Iasonos, Roisin E. O’Cearbhaill, Dennis S. Chi, Kara C. Long Roche, Edward J. Tanner, John Denesopolis, Richard R. Barakat, Oliver Zivanovic

International Journal of Gynecologic Cancer May 2015, 25 (4) 599-606; DOI: 10.1097/IGC.0000000000000389
Does Modality of Adjuvant Chemotherapy After Interval Surgical Debulking Matter in Epithelial Ovarian Cancer?: An Exploratory Analysis
Nashmia Joudallah Al Mutairi, Tien Le

International Journal of Gynecologic Cancer Mar 2014, 24 (3) 461-467; DOI: 10.1097/IGC.0000000000000066
Extraperitoneal Metastases From Recurrent Ovarian Cancer
William R. Robinson, Julie Beyer, Stephen Griffin, Paiyarut Kanjanavaikoon

International Journal of Gynecologic Cancer Jan 2012, 22 (1) 43-46; DOI: 10.1097/IGC.0b013e31823532ce
Intraperitoneal Catheter Leads to Prolongation of the Time to Normalization of Serum CA125 Levels
Scott D. Richard, Paniti Sukumvanich, Jamie L. Lesnock, William C. McBee, Sushil Beriwal, Robert P. Edwards, Kristin K. Zorn, Thomas C. Krivak

International Journal of Gynecologic Cancer Jul 2010, 20 (6) 932-935; DOI: 10.1111/IGC.0b013e3181e37a54
Factors Affecting the Completion of Intraperitoneal Chemotherapy in Women With Ovarian Cancer
William R. Robinson, Julie Beyer

International Journal of Gynecologic Cancer Jan 2010, 20 (1) 70-74; DOI: 10.1111/IGC.0b013e3181c7f670
Intraperitoneal Chemotherapy by Ultrasound-Guided Direct Puncture in Recurrent Ovarian Cancer: Feasibility, Compliance, and Complications
Pierluigi Benedetti-Panici, Giorgia Perniola, Claudia Marchetti, Milena Pernice, Cristina Donfrancesco, Violante Di Donato, Federica Tomao, Innocenza Palaia, Marialida Graziano, Stefano Basile, Filippo Bellati

International Journal of Gynecologic Cancer Jul 2012, 22 (6) 1069-1074; DOI: 10.1097/IGC.0b013e31825736b2
Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Recurrent Endometrial Carcinoma Confined to the Peritoneal Cavity
Naoual Bakrin, Eddy Cotte, Anne Sayag-Beaujard, Daniel Raudrant, Sylvie Isaac, Faheez Mohamed, François-Noel Gilly, Olivier Glehen

International Journal of Gynecologic Cancer Jun 2010, 20 (5) 809-814; DOI: 10.1111/IGC.0b013e3181a83f7e

Main menu

Intraperitoneal chemotherapy

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Intraperitoneal chemotherapy

Pages